Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07156370 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Salivary Cortisol and Hypercortisolism in Type 2 Diabetes

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date changed from estimate of Sep 1, 2025 to Sep 11, 2025 Site contact updatedv2 Show 1 more changeShow less
    • Site contact updated
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this observational study is to explore the prevalence of hypercortisolism in a population with difficult to control type 2 diabetes despite receiving standard-of-care therapies. Additionally, the study will evaluate the correlation between salivary cortisol levels and glycemic control.
Trial Details
NCT Number NCT07156370
Lead Sponsor Shanghai 6th People's Hospital
Conditions Hypercortisolism, Type 2 Diabetes (T2DM)
Enrollment 500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov